🇺🇸 FDA

Company profile · Sponsor

Kamada

Kamada BioPharma Limited at Fieldfisher LLP

E30BC57 · EMA biotech GB
Pipeline
1
Drugs
0
Patents
0

Quick answer

Kamada (E30BC57) is a biotech company. headquartered in GB. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E30BC57
Exchange EMA
Company type biotech
Headquarters GB

Pipeline (1)

Search pipeline →

  1. Kamada-AAT for Inhalation, Placebo for “Kamada-AAT for Inhalation”

    Kamada

    Adult Patients with Congenital Alpha-1 Antitrypsin Deficiency with Moderate and Severe Airflow Limitation (40% ≤ FEV1 ≤ 80% of predicted; FEV1/SVC ≤ 70%), and with no history of two or more moderate or one or more severe exacerbations of COPD during the past year.

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Kamada?

Kamada (E30BC57) is a biotech company. headquartered in GB. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Kamada sponsor?

We track 1 ClinicalTrials.gov-linked program for Kamada, including Kamada-AAT for Inhalation, Placebo for “Kamada-AAT for Inhalation”. Open each program for phase, modality, NCT IDs, and indication details.

Where does Kamada company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.